Status:

RECRUITING

Neutrophils to Lymphocytes and Platelets Ratio, Procalcitonin, and Total Leucocytic Count as Indicators of Prognostic Outcome in Septic Patients in the Intensive Care Unit.

Lead Sponsor:

Ain Shams University

Conditions:

Neutrophils to Lymphocytes

Platelets

Eligibility:

All Genders

18-70 years

Brief Summary

This study aims to compare Neutrophil to Lymphocyte and Platelet Ratio, Procalcitonin, and Total Leucocyte Count as indicators of prognostic outcome in septic patients in the intensive care unit.

Detailed Description

Sepsis affects more than 30 million people annually worldwide and is one of the significant causes of death in critical patients worldwide. Any infected person can potentially develop sepsis, and the ...

Eligibility Criteria

Inclusion

  • Age from 18 to 70 years old.
  • Both sexes.
  • Septic patients (under the third international consensus definitions of sepsis and septic shock).

Exclusion

  • Pregnancy
  • Malignancy
  • On immunosuppressive therapy
  • Hematological Disorders
  • Major Trauma
  • Major Burns
  • Child-Pugh Class C Liver Cirrhosis
  • On Hemodialysis

Key Trial Info

Start Date :

September 20 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 19 2026

Estimated Enrollment :

290 Patients enrolled

Trial Details

Trial ID

NCT07200817

Start Date

September 20 2024

End Date

March 19 2026

Last Update

October 1 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ain Shams University

Cairo, Egypt, 11591

Neutrophils to Lymphocytes and Platelets Ratio, Procalcitonin, and Total Leucocytic Count as Indicators of Prognostic Outcome in Septic Patients in the Intensive Care Unit. | DecenTrialz